528 related articles for article (PubMed ID: 12688021)
1. [Overweight patient has tried many times to lose weight. What helps against stubborn fat padding?].
Wirth A
MMW Fortschr Med; 2003 Mar; 145(10):16. PubMed ID: 12688021
[No Abstract] [Full Text] [Related]
2. [What effect does losing weight have on hypertension?].
Engeli S
MMW Fortschr Med; 2003 Jul; 145(27-28):44. PubMed ID: 14587188
[No Abstract] [Full Text] [Related]
3. [A drug help in reducing? Risk profile decides whether and how].
Hauner H
MMW Fortschr Med; 2003 May; 145(21):60. PubMed ID: 12845877
[No Abstract] [Full Text] [Related]
4. [Struggle about the best reducing diet, Fat gone by means of more fat?].
Bischoff A
MMW Fortschr Med; 2004 Jan; 146(1-2):4-6. PubMed ID: 18441569
[No Abstract] [Full Text] [Related]
5. Medical strategies for weight loss in the overweight and obese patient.
Di Caro S; Hamad GG; Fernstrom MH; Schauer PR; Bonanomi G
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):415-30. PubMed ID: 17108871
[TBL] [Abstract][Full Text] [Related]
6. [No progress without the physician in therapy of obesity].
Schmidt H; Plauth M
MMW Fortschr Med; 2000 Jan; 142(4):35-6. PubMed ID: 10850095
[No Abstract] [Full Text] [Related]
7. [New drugs for the treatment of obesity].
Mustajoki P
Duodecim; 1999; 115(20):2191, 2193-4. PubMed ID: 11973921
[No Abstract] [Full Text] [Related]
8. [Pharmacotherapy in the treatment of obesity].
Hamann A
MMW Fortschr Med; 2006 Mar; 148(9):36-8. PubMed ID: 16566392
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic therapies for obesity.
Kaplan LM
Gastroenterol Clin North Am; 2010 Mar; 39(1):69-79. PubMed ID: 20202580
[TBL] [Abstract][Full Text] [Related]
10. Prevention and management of obesity: pharmacology .
Finer N
Proc Nutr Soc; 2000 Aug; 59(3):413. PubMed ID: 10997657
[No Abstract] [Full Text] [Related]
11. Pharmacologic agents for the treatment of obesity.
Mathys M
Clin Geriatr Med; 2005 Nov; 21(4):735-46, vii. PubMed ID: 16182086
[TBL] [Abstract][Full Text] [Related]
12. Long-term pharmacotherapy for obesity.
Klein S
Obes Res; 2004 Dec; 12 Suppl():163S-6S. PubMed ID: 15687412
[TBL] [Abstract][Full Text] [Related]
13. Diets, drugs, exercise, and behavioral modification: Where these work and where they do not.
Kushner R
Surg Obes Relat Dis; 2005; 1(2):120-2. PubMed ID: 16925226
[No Abstract] [Full Text] [Related]
14. [Weight reduction. Antiobesity drug treatment in type-2 diabetics].
Verspohl EJ
Pharm Unserer Zeit; 2002; 31(3):300-7. PubMed ID: 12071127
[No Abstract] [Full Text] [Related]
15. [How safe are the new obesity drugs? Indications and contraindications of orlistat and sibutramine].
Richter WO
MMW Fortschr Med; 1999 Dec; 141(49-50):32-6. PubMed ID: 10726144
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacotherapy of obesity].
Svendsen OL
Ugeskr Laeger; 2004 Oct; 166(43):3814-7. PubMed ID: 15544112
[No Abstract] [Full Text] [Related]
17. The new role of pharmacotherapy for weight reduction in obesity.
Fernstrom MH; Fernstrom JD
Int J Clin Pract; 2002 Nov; 56(9):683-6. PubMed ID: 12469983
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacotherapy for weight loss in patients with type 2 diabetes].
Toubro S
Ugeskr Laeger; 2007 Aug; 169(33):2619-22. PubMed ID: 17725907
[No Abstract] [Full Text] [Related]
19. Combining behavioral and pharmacological treatments for obesity.
Phelan S; Wadden TA
Obes Res; 2002 Jun; 10(6):560-74. PubMed ID: 12055334
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological treatments for obesity.
McLoughlin C
Prof Nurse; 2005 Apr; 20(8):50-1. PubMed ID: 15819320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
